Evoke plc (LON:EVOK – Get Free Report) shares traded down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
EVOK has been the topic of a number of research reports. Berenberg Bank decreased their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a report on Monday, December 16th.
Get Our Latest Stock Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, analysts predict that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 03/24 – 03/28
- Investing In Automotive Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How is Compound Interest Calculated?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.